Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Price: 62.99 for Nov. 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 01, 2024 | 63.36 | 63.39 | 62.85 | 62.99 | 23786.00 |
Oct 31, 2024 | 61.49 | 61.91 | 61.44 | 61.67 | 23835.00 |
Oct 30, 2024 | 61.52 | 62.26 | 61.46 | 61.84 | 29069.00 |
Oct 29, 2024 | 62.42 | 62.84 | 62.38 | 62.54 | 15981.00 |
Oct 28, 2024 | 64.12 | 64.20 | 63.36 | 63.56 | 27072.00 |
Oct 25, 2024 | 63.94 | 64.20 | 63.85 | 63.92 | 188415.0 |
Oct 24, 2024 | 64.73 | 65.12 | 63.79 | 64.12 | 39694.00 |
Oct 23, 2024 | 62.75 | 62.94 | 61.99 | 62.26 | 191692.0 |
Oct 22, 2024 | 62.44 | 62.55 | 62.15 | 62.42 | 87199.00 |
Oct 21, 2024 | 62.69 | 62.72 | 62.55 | 62.55 | 13413.00 |
Oct 18, 2024 | 63.50 | 63.96 | 63.44 | 63.85 | 43050.00 |
Oct 17, 2024 | 63.06 | 63.72 | 63.06 | 63.50 | 33415.00 |
Oct 16, 2024 | 62.56 | 62.65 | 61.82 | 61.91 | 28540.00 |
Oct 15, 2024 | 63.00 | 63.00 | 62.04 | 62.04 | 12369.00 |
Oct 14, 2024 | 62.16 | 62.90 | 62.16 | 62.90 | 12911.00 |
Oct 11, 2024 | 61.70 | 61.84 | 61.01 | 61.37 | 29355.00 |
Oct 10, 2024 | 60.84 | 60.84 | 60.58 | 60.77 | 14637.00 |
Oct 09, 2024 | 61.68 | 61.89 | 61.46 | 61.80 | 18224.00 |
Oct 08, 2024 | 61.40 | 61.83 | 61.40 | 61.53 | 18414.00 |
Oct 07, 2024 | 61.46 | 61.60 | 61.23 | 61.36 | 24820.00 |
Oct 04, 2024 | 61.32 | 61.48 | 60.90 | 61.48 | 13883.00 |
Oct 03, 2024 | 62.72 | 62.72 | 62.23 | 62.39 | 21037.00 |
Oct 02, 2024 | 62.23 | 62.76 | 62.23 | 62.44 | 18020.00 |
Oct 01, 2024 | 64.13 | 64.13 | 62.96 | 63.35 | 19241.00 |
Sep 30, 2024 | 63.78 | 63.78 | 62.94 | 63.17 | 25865.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
32.32
Minimum
Mar 23 2020
85.40
Maximum
Aug 27 2021
57.99
Average
58.86
Median
Price Benchmarks
AC Immune SA | 3.00 |
CRISPR Therapeutics AG | 50.76 |
Addex Therapeutics Ltd | 10.70 |
NLS Pharmaceutics Ltd | 3.60 |
Molecular Partners AG | 6.12 |
Price Related Metrics
PE Ratio | 71.05 |
PS Ratio | 6.089 |
Price to Book Value | 4.367 |
Earnings Yield | 1.41% |
Market Cap | 45.43B |
Operating PE Ratio | 47.30 |
Normalized PE Ratio | 63.03 |